Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery
NCT01912651Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Sep 2011
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefalexin in craniofacial abnormality (CFA), sponsored by University of Michigan. Started Sep 2011; status: completed.
02
Drugs
cefalexin
03
Conditions
craniofacial abnormality (CFA)
Beyond the preview
Go deeper on NCT01912651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912651.